Plasmagen Biosciences
Bengaluru, IN · Founded 2010 · 436 employees on LinkedIn · 1 known investors
PlasmaGen BioSciences is a biopharmaceutical company focused on plasma protein and specialty care therapies, offering products across medical specialities such as neurology, haematology, oncology, immunology and critical care. It serves patients in India and other developing economies, working with government bodies on affordability, accessibility and hemovigilance.
Investors · 1
Competitors · 8
by search overlap
Biogen Idec68 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
PepGen49 shared keywordsPepGen develops disease-modifying therapeutics aimed at the underlying causes of serious genetic neuromuscular and neurological diseases. The company is building a pipeline of oligonucleotide-based treatments for these conditions.
Amgen44 shared keywordsAmgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
Urogen26 shared keywordsUroGen is a biopharmaceutical company developing and commercializing treatments for urological cancers, including FDA-approved therapies such as JELMYTO and ZUSDURI built on its RTGel technology. Its pipeline focuses on uro-oncology indications like non-muscle invasive bladder cancer.
Wugen24 shared keywordsAllotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.
NervGen Pharma21 shared keywordsNervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair. It maintains a drug pipeline and operates as a publicly traded company.
Macrogenics Inc20 shared keywordsMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
Globaldata19 shared keywordsGlobalData provides an AI-powered intelligence platform that delivers research, market analysis, and predictive insights to enterprises across industries. The platform combines proprietary data, in-house subject matter experts, and AI tools to support critical business decisions.
Companies competing with Plasmagen Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Plasmagen Biosciences do?
- PlasmaGen BioSciences is a biopharmaceutical company focused on plasma protein and specialty care therapies, offering products across medical specialities such as neurology, haematology, oncology, immunology and critical care. It serves patients in India and other developing economies, working with government bodies on affordability, accessibility and hemovigilance.
- Who are Plasmagen Biosciences's investors?
- Plasmagen Biosciences's investors include F-Prime Capital.
- Where is Plasmagen Biosciences headquartered?
- Plasmagen Biosciences is headquartered in Bengaluru, IN.